81100-05-2

Upstream product

• 108-24-7 acetic anhydride 
• 81082-05-5 Docosanoic acid 1-[(R)-2-((2R,3R,4R,5R)-4-acetylamino-5-benzyloxy-3-{(R)-1-[(S)-1-((R)-3-benzyloxycarbonyl-1-carbamoyl-propylcarbamoyl)-ethylcarbamoyl]-ethoxy}-tetrahydro-furan-2-yl)-2-hydroxy-ethoxycarbonyl]-1-methyl-ethyl ester 
• 58886-33-2 benzyl 2-acetamido-2-deoxy-5,6-O-isopropylidene-β-D-glucofuranoside 
• 81082-01-1 benzyl 2-acetamido-2-deoxy-3-O-<(R)-2-propionyl-L-alanyl-D-isoglutamine benzyl ester>-β-D-glucofuranoside 
• 69323-70-2 benzyl 2-acetamido-2-deoxy-5,6-O-isopropylidene-3-O-<(R)-2-propionyl-L-alanyl-D-isoglutamine benzyl ester>-β-D-glucofuranoside 
• 81082-00-0 benzyl 2-acetamido-3-O-<(R)-1-carboxyethyl>-2-deoxy-5,6-O-isopropylidene-β-D-glucofuranoside 

Relevant academic research and scientific papers

Synthesis and Immunoadjuvant Activities of 2-Acetamido-5-O-acetyl-6-O-acyl-2-deoxy-3-O--D-glucofuranoses as Potential Prodrug Forms of 6-O-Acyl Derivatives of N-Acetylmuramyl Dipeptide

2-Acetamido-5-O-acetyl-6-O-acyl-2-deoxy-3-O--D-glucofuranoses, designed as prodrug forms of the corresponding immunoadjuvant-active 6-O-acyl derivatives of N-acetylmuramyl dipeptide (MDP), were synthesized from ben